Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease

Abstract

Chagas disease is initiated upon infection by Trypanosoma cruzi. Among the health consequences is a decline in heart function, and the pathophysiological mechanisms underlying this manifestation are not well understood. To explore the possible mechanisms, we employed IgY LC10 affinity chromatography in conjunction with ProteomeLab PF2D and two-dimensional gel electrophoresis to resolve the proteome signature of high and low abundance serum proteins in chagasic patients. MALDI-TOF MS/MS analysis yielded 80 and 14 differentially expressed proteins associated with cardiomyopathy of chagasic and other etiologies, respectively. The extent of oxidative stress-induced carbonyl modifications of the differentially expressed proteins (n ‫؍‬ 26) was increased and coupled with a depression of antioxidant proteins. Functional annotation of the top networks developed by ingenuity pathway analysis of proteome database identified dysregulation of inflammation/acute phase response signaling and lipid metabolism relevant to production of prostaglandins and arachidonic acid in chagasic patients. Overlay of the major networks identified prothrombin and plasminogen at a nodal position with connectivity to proteome signature indicative of heart disease (i.e., thrombosis, angiogenesis, vasodilatation of blood vessels or the aorta, and increased permeability of blood vessel and endothelial tubes), and inflammatory responses (e.g., platelet aggregation, complement activation, and phagocyte activation and migration). The detection of cardiac proteins (myosin light chain 2 and myosin heavy chain 11) and increased levels of vinculin and plasminogen provided a comprehensive set of biomarkers of cardiac muscle injury and development of clinical Chagas disease in human patients. These results provide an impetus for biomarker validation in large cohorts of clinically characterized chagasic patients. Molecular & Cellular

Vitamin D-binding protein controls T cell responses to vitamin D

“…This suggested that carbonylated DBP is found in human serum as recently described for rat serum [55]. To investigate whether carbonylated DBP is found in human serum we immunoprecipitated DBP from freshly drawn human blood and either derivatized it with 2,4-dinitrophenyl hydrazine to detect carbonylated DBP or left it untreated before Western blot analysis with anti-DNP antibodies.…”

“…Carbonylation is a protein modification induced by oxidative stress [54], and increased carbonylation of serum proteins including DBP is seen during inflammatory responses [55-57]. Carbonylation of DBP could lead to a higher concentration of free 25(OH)D 3 due to a reduced affinity of carbonylated DBP for 25(OH)D3 and/or increased degradation of DBP.…”

Circulating microRNAs in obese and lean heart failure patients: A case–control study with computational target prediction analysis

“…ETS1, GATA2 and AR modulate the activity of vinculin (VCL), which has been previously associated with dilated cardiomyopathy [57,58]. Furthermore, we found that GATA2 is a regulator of NPPB, which encodes BNP, a well-established clinical biomarker for decompensated heart failure [59].…”

Opportunities and Challenges in Chronic Chagas Cardiomyopathy

“…Research by Wen et al [51] focused on improving the ability to diagnose Chagas disease identified a proteomic signature for patients with CCC to allow for earlier detection of disease. Another study focused on the development of therapeutic approaches using stem cells as alternatives to transplantation.…”